Aceso Stem Biostrategies Inc

CynosBio

This company develops regenerative medicine products, including autologous cell therapies for ophthalmology and orthopaedics, serving healthcare professionals and patients with severe unmet medical needs.

BONE THERAPEUTICS

This biotechnology company develops allogeneic cell therapy products for patients suffering from orthopaedic conditions and bone diseases.

Satellos Bioscience

This company develops oral small molecule drugs to restore muscle regeneration for patients with Duchenne muscular dystrophy and other degenerative muscle diseases.

Athersys

Athersys develops regenerative stem cell therapies to treat patients with neurological, inflammatory, and cardiovascular conditions, primarily through its proprietary off-the-shelf MultiStem cell platform.

Altach Biomedical

This company develops biomimetic collagen scaffolds to regenerate damaged joint cartilage for patients with musculoskeletal injuries and osteoarthritis.

MyoPax

This company develops muscle regeneration cell and gene therapies for patients with congenital malformations, trauma, hereditary dystrophies and muscle wasting disorders.

Satellos

This company develops small molecule therapeutics to restore muscle regeneration for patients with Duchenne muscular dystrophy and other degenerative muscle diseases.

VascVersa Ltd

This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.